Neovascular age-related macular degeneration: 18-month outcomes of aflibercept treatment in patients resistant to ranibizumab
Journal Title: The European Research Journal - Year 2019, Vol 5, Issue 6
Abstract
Objectives: Aim of this study is to investigate the effect of intravitreal aflibercept therapy in an 18-month period in patients with recurrent neovascular age-related macular degeneration resistant to intravitreal ranibizumab. Methods: This is a prospective study of eyes with neovascular age-related macular degeneration switched to intravitreal aflibercept with at least 18 month of follow-up after the switch. All patients had had a minimum of 6 injections of ranibizumab before the switch. All patients received a loading dose of three intravitreal 2 mg aflibercept injections at 4-week intervals. Changes in best-corrected visual acuity, central macular thickness and the frequency of injections were compared. Results: The study included 39 patients, each with one diseased eye. The studied eyes had received an average of 10.74 ± 4.38 previous intravitreal ranibizumab injections over a period of 28.31 ± 18.08 months. During the study, an average of 6.94 ± 2.58 intravitreal aflibercept injections were given in a period of 18 months. Mean central macular thickness at baseline, before switching to aflibercept, 6, 12, and 18 months after the aflibercept injection were 327.44 ± 120.57, 354.50 ± 127.79, 290.20 ± 112.25, 311.70 ± 119.47, and 299.29 ± 98.38 μm, respectively. A significant change was found in the macular thickness measured at intervals throughout the study. However, no significant improvement was found in visual acuity after 18 month after switching to aflibercept. Conclusions: Switching from intravitreal ranibizumab, an inhibitor of vascular endothelial growth factor-A, to aflibercept, another inhibitor for such factors, has increased central macular thickness significantly without changes in visual acuity.
Authors and Affiliations
Elif Ertan, Mustafa Doğan
Keywords
Related Articles
- EP ID EP665250
- DOI 10.18621/eurj.446300
- Views 65
- Downloads 0
Effects of a single dose 20 mg tadalafil on resistive index value of prostate zones
Objectives: Although there are several studies addressing the efficacy of phosphodiesterase type 5 inhibitors for the management of benign prostatic hyperplasia-lower urinary tract symptoms (BPH-LUTS), unfortunately, the...
The correlation between red cell distribution width, autoimmunity and nail involvement in alopecia areata
Objectives: Alopecia areata is a widespread autoimmune disease that targets hair follicles, and is characterized by nonscarring patches of hair loss. Red cell distribution width (RDW) is a routinely analyzed parameter du...
Coenzyme Q10 deficiency in elderly: Can nutritional supplementation play a role? Mini review
Coenzyme Q10 (CoQ10), an important mitochondrial redox component, plays a pivotal role in cellular energy production; moreover, it is the only lipid-soluble antioxidant endogenously synthesized in humans. Given its funct...
The drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients
Objectives: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) control among hypertensive patients that have uncontrolled and controlled BP. Methods: Seventy-eight uncontrolled BP an...
Evaluation of Tp-e interval and Tp-e/ QTc ratio in patients with mild to moderate psoriasis
Objectives. Many systemic diseases including cardiovascular disturbances have been described in psoriatic patients. In the previous studies, left ventricle (LV) subclinical myocardial dysfunction was reported in the psor...